(Editor’s note: SDGLN is not reporting on the 2012 San Diego mayoral race because SDGLN Publisher Johnathan Hale has a personal relationship with City Councilmember Carl DeMaio, who is running for mayor. SDGLN will also not be making an endorsement in the race.
For the first time in San Diego history, the mayoral race has two prominent LGBT candidates: DeMaio and District Attorney Bonnie Dumanis. Although SDGLN will not be reporting on the mayoral race, we will, as a service to the LGBT community, publish selected press releases by DeMaio and Dumanis to inform our readers about their campaigns. These press releases will be clearly labeled as such so that readers understand they are not written by SDGLN staff members.
In addition, all candidates for any political race are allowed to submit two pieces per month for our Commentary page. SDGLN Editor in Chief Ken Williams can be reached at email@example.com, @KenSanDiego on Twitter or at (877) 727-5446, x713.)
THIS IS A PRESS RELEASE FROM THE BONNIE DUMANIS CAMPAIGN
SAN DIEGO -- Reaffirming her commitment to making San Diego a thriving "start-up" city, Mayoral candidate Bonnie Dumanis toured La Jolla’s Janssen Labs, the newest innovation center for fledging companies pursing new bio-technologies and research platforms to advance medical care.
"Janssen Labs is doing for San Diego's bio-tech start-ups what EvoNexus has done for San Diego's high-tech start-ups. They’re bringing together, under one roof, some of the brightest and most promising San Diego companies in a shared facility. The result is an environment that nurtures and supports creativity and innovation. So-called ‘incubators’ are critical to keeping San Diego at the forefront of the bio-tech industry and, more importantly, creating jobs for our region," said Dumanis.
Dr. Diego Miralles gives Mayoral candidate Bonnie Dumanis a preview of the new Janssen Labs bio-tech 'incubator.'
“’Incubators’ like Janssen Labs are an important part of my vision to elevate San Diego on the world stage, solidifying our city as a leader in international commerce and supporter of innovative new technologies.”
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. has converted 35,000 square feet of research and office space into an "incubator lab" at the company's La Jolla-based West Coast Research Center. The Center is designed to reduce initial costs for biotech companies committed to bringing new drugs and devices to consumers faster.
Johnson & Johnson has plans to recruit as many as 20 small companies to occupy the lab. The structure allows the start-ups to focus their limited funding on the research rather than costly capital investments. Each company pays a reduced rent fee, then shares access to several expensive research devices and are afforded the bulk supply purchasing ability under the Johnson & Johnson corporate umbrella.